Marjolein van der Poel

Research activity per year

58 Article
4 Comment/Letter to the editor
3 Erratum / corrigendum / retractions
2 (Systematic) Review article
More
- 1 Editorial
- 1 Doctoral Thesis

3 results

Filter

2021

Correction to: Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation
Percival, M.-E., Wang, H.-L., Zhang, M.-J., Saber, W., de Lima, M., Litzow, M., Kebriaei, P., Abdel-Azim, H., Adekola, K., Aljurf, M., Bacher, U., Badawy, S. M., Beitinjaneh, A., Bejanyan, N., Bhatt, V., Byrne, M., Cahn, J.-Y., Castillo, P., Chao, N. & Chhabra, S. & 47 others, Copelan, E., Cutler, C., DeFilipp, Z., Dias, A., Diaz, M. A., Estey, E., Farhadfar, N., Frangoul, H. A., Freytes, C. O., Gale, R. P., Ganguly, S., Gowda, L., Grunwald, M., Hossain, N., Kamble, R. T., Kanakry, C. G., Kansagra, A., Kharfan-Dabaja, M. A., Krem, M., Lazarus, H. M., Lee, J. W., Liesveld, J. L., Lin, R., Liu, H., McGuirk, J., Munker, R., Murthy, H. S., Nathan, S., Nishihori, T., Olsson, R. F., Palmisiano, N., Passweg, J. R., Prestidge, T., Ringdén, O., Rizzieri, D. A., Rybka, W. B., Savoie, M. L., Schultz, K. R., Seo, S., Sharma, A., Solh, M., Strair, R., van der Poel, M., Verdonck, L. F., Yared, J. A., Weisdorf, D. & Sandmaier, B. M., Sept 2021, In: Bone Marrow Transplantation. 56, 9, p. 2319-2319 1 p., 2319.
Research output: Contribution to journal › Erratum / corrigendum / retractions › Academic

Open Access
Erratum: Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation; a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research
Lazaryan, A., Dolan, M., Zhang, M. J., Wang, H. L., Kharfan-Dabaja, M. A., Marks, D. I., Bejanyan, N., Copelan, E., Majhail, N. S., Waller, E. K., Chao, N., Prestidge, T., Nishihori, T., Kebriaei, P., Inamoto, Y., Hamilton, B., Hashmi, S. K., Kamble, R. T., Bacher, U. & Hildebrandt, G. C. & 31 others, Stiff, P. J., McGuirk, J., Aldoss, I., Beitinjaneh, A. M., Muffly, L., Vij, R., Olsson, R. F., Byrne, M., Schultz, K. R., Aljurf, M., Seftel, M., Savoie, M. L., Savani, B. N., Verdonck, L. F., Cairo, M. S., Hossain, N., Bhatt, V. R., Frangoul, H. A., Abdel-Azim, H., Al Malki, M., Munker, R., Rizzieri, D., Khera, N., Nakamura, R., Ringdén, O., Van Der Poel, M., Murthy, H. S., Liu, H., Mori, S., De Oliveira, S. & Acute Leukemia Committee of the CIBMTR, 1 Aug 2021, In: Haematologica-the Hematology Journal. 106, 8, p. 2295-2296 2 p.
Research output: Contribution to journal › Erratum / corrigendum / retractions › Academic

Open Access
2020
Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS
Ossenkoppele, G. J., Breems, D. A., Stuessi, G., van Norden, Y., Bargetzi, M., Biemond, B. J., A von dem Borne, P., Chalandon, Y., Cloos, J., Deeren, D., Fehr, M., Gjertsen, B., Graux, C., Huls, G., Janssen, J. J. J. W., Jaspers, A., Jongen-Lavrencic, M., de Jongh, E., Klein, S. K. & van der Klift, M. & 15 others, van Marwijk Kooy, M., Maertens, J., Michaux, L., van der Poel, M. W. M., van Rhenen, A., Tick, L., Valk, P., Vekemans, M. C., van der Velden, W. J. F. M., de Weerdt, O., Pabst, T., Manz, M., Löwenberg, B., Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) & Swiss Group for Clinical Cancer Research (SAKK), Oct 2020, In: Leukemia. 34, 10, p. 2820-2820 1 p., 2820.
Research output: Contribution to journal › Erratum / corrigendum / retractions › Academic

Open Access

Marjolein van der Poel

Research output

Search results

Correction to: Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation

Erratum: Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation; a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research

Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS